From here, there is quite a drop-off in terms of overall asset levels in the remaining funds in the category, but just across the aforementioned funds an obvious takeaway here is that there are notable asset levels, and growing asset levels given what we have seen thus far in 2015 and in general with investors seeming to add to positions on weakness.

iShares Nasdaq Biotechnology ETF

For more information on Street One ETF market commentary and ETF trade execution/liquidity services, contact Paul Weisbruch at pweisbruch@streetonefinancial.com

Street One Financial is an educational/research firm utilizing the Broker Dealer services of Precision Securities, a FINRA registered Broker/Dealer.